ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.331,39
-0,25%
S&P 500
5.469,30
0,39%
US Dollar vs BRL
5,4522
0,00%
Bitcoin
61.707,19
-0,15%
Brent Oil
84,65
0,55%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Biofrontera Inc (BFRIW)

  7. Biofrontera Inc (BFRIW) Notícias

BFRIW

Biofrontera (BFRIW)

Biofrontera Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BFRIW
DataHoraFonteTítuloCódigoCompanhia
24/06/202409:30GlobeNewswire Inc.Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL LampNASDAQ:BFRIWBiofrontera Inc
14/06/202417:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
22/05/202417:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BFRIWBiofrontera Inc
10/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BFRIWBiofrontera Inc
16/12/202210:30GlobeNewswire Inc.Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of StockholdersNASDAQ:BFRIWBiofrontera Inc
30/11/202216:08GlobeNewswire Inc.Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
28/11/202213:05GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022NASDAQ:BFRIWBiofrontera Inc
21/11/202210:48GlobeNewswire Inc.Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and TrunkNASDAQ:BFRIWBiofrontera Inc
14/11/202210:45GlobeNewswire Inc.Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
10/11/202213:52GlobeNewswire Inc.Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022NASDAQ:BFRIWBiofrontera Inc
08/11/202218:45GlobeNewswire Inc.Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AGNASDAQ:BFRIWBiofrontera Inc
31/10/202209:55GlobeNewswire Inc.Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AGNASDAQ:BFRIWBiofrontera Inc
24/10/202208:45GlobeNewswire Inc.Biofrontera Inc. Names Fred Leffler as Chief Financial OfficerNASDAQ:BFRIWBiofrontera Inc
20/10/202212:40GlobeNewswire Inc.Biofrontera Inc. to Present at the LD Micro Main Event XV Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
18/10/202211:30GlobeNewswire Inc.Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology ConferenceNASDAQ:BFRIWBiofrontera Inc
14/10/202209:40GlobeNewswire Inc.Biofrontera Inc. Adopts Limited Duration Shareholder Rights PlanNASDAQ:BFRIWBiofrontera Inc
12/10/202215:00GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022NASDAQ:BFRIWBiofrontera Inc
05/10/202218:00GlobeNewswire Inc.Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022NASDAQ:BFRIWBiofrontera Inc
29/09/202211:04GlobeNewswire Inc.Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities ConferenceNASDAQ:BFRIWBiofrontera Inc
26/09/202209:30GlobeNewswire Inc.Biofrontera Inc.’s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer AwardsNASDAQ:BFRIWBiofrontera Inc
13/09/202209:30GlobeNewswire Inc.Biofrontera Inc. Names Gerard DiGirolamo as National Sales DirectorNASDAQ:BFRIWBiofrontera Inc
06/09/202211:31GlobeNewswire Inc.Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion Composition-of-Matter U.S. PatentNASDAQ:BFRIWBiofrontera Inc
18/08/202212:04GlobeNewswire Inc.Biofrontera Inc.’s Leslie Hopkins Named PM360 Trailblazer 2022 Brand Champion for DermatologyNASDAQ:BFRIWBiofrontera Inc
12/08/202209:33GlobeNewswire Inc.Biofrontera Inc. Reports Second Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
04/08/202209:30GlobeNewswire Inc.Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022NASDAQ:BFRIWBiofrontera Inc
01/08/202212:00GlobeNewswire Inc.Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbHNASDAQ:BFRIWBiofrontera Inc
27/07/202209:45GlobeNewswire Inc.Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private PlacementNASDAQ:BFRIWBiofrontera Inc
12/07/202209:00GlobeNewswire Inc.Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022NASDAQ:BFRIWBiofrontera Inc
09/06/202210:44GlobeNewswire Inc.Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing ExcellenceNASDAQ:BFRIWBiofrontera Inc
31/05/202211:42GlobeNewswire Inc.Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 ConferenceNASDAQ:BFRIWBiofrontera Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BFRIW

Seu Histórico Recente

LSE
RMP
Red Emperor Resources Nl
NASDAQ
CABLW
AMEX
FSMB
First Trust Short Durati...
DBI
IN4M
India Government Bond UC...
NYSE
RENX
RELX N.V.
USOTC
IMAHF
Highcliff Metals (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados